Summary
Glucocorticoids and β2-agonists may regulate gene transcription in a cell- and gene-specific manner at both the transcriptional and post-transcriptional level. For this transcription factor interaction to be of importance in asthma, it must occur in a cell or cells which are key targets for steroids and which also express surface β2-receptors and respond to β2-agonist stimulation with elevation of cAMP. Many pulmonary cells express β2-receptors and these same cells express GR. Airway epithelial cells, T-lymphocytes and macrophages are target cells an which this effect may be of therapeutic relevance, particularly as all produce cytokines which may orchestrate or perpetuate the allergic inflammatory response.
Asthma is due to a chronic inflammation of the airways and glucocorticoids are the most effective therapy currently available for the control of asthmatic inflammation. Indeed, inhaled steroids have now become the mainstay of chronic asthma therapy. Whereas β-agonists are most effective in treating the airways constriction associated with the onset of asthma symptoms and are often the only drug prescribed for the treatment of mild asthmatics although even at this stage of the disease there may well be ongoing, possibly irreversible, inflammatory changes in the airway [1]. β-Adrenoreceptor agonists and glucocorticoids are the two most effective treatments for asthma and are often used in combination. In this chapter we summarise the interactions between these drugs at a biochemical and molecular level and discuss the possible consequences for asthma therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnes PJ (1995) Inhaled glucocorticoids for asthma. N Engl J Med 332: 868–875
Munck A, Guyre PM, Holbrook NJ (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Revs 5: 25–44
Truss M, Beato M (1993) Steroid hormone receptors: interaction with deoxyribo-nucleic acid and transcription factors. Endocrine Revs 14: 459–479
Truss M, Chalepakis G, Beato M (1992) Interplay of steroid hormone receptors and transcription factors on the mouse mammary tumour virus promoter. J Steroid Biochem Molec Biol 43: 365–378
Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P (1990) Antitumour promotion and antiinflammation: down-modulation of AP-1 ( Fos/Jun) activity by glucocorticoid hormone. Cell 62: 1189–1204
Ray A, Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-KB and the glucocorticoid receptor. Proc Nat Acad Sci (USA) 91: 752–756
Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ (1995) Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 268: C331 — C338
Adcock IM, Gelder CM, Shirasaki H, Yacoub M, Barnes PJ (1992) Effects of steroids on transcription factors in human lung. Am Rev Respir Dis 143: A834
Adcock IM, Shirasaki H, Gelder CM, Peters MJ, Brown CR, Barnes PJ (1994) The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 55: 1147–1153
Barnes PJ, Adcock IM (1993) Antiinflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14: 436–441
Janknecht R, Hunter T (1996) A growing co-activator network. Nature 383: 22–23
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403–414
Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996) Role of CBP/P300 in nuclear receptor signalling. Nature 383: 99–103
Smith CL, Onate SA, Tsai M-J, O’Malley BW (1996) CREB binding protein acts synergistically with steroid receptor co-activator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 93: 8884–8888
Zhang X, Jeyakumar M, Bagchi MK (1996) Ligand-dependent cross-talk between steroid and thyroid receptors. J Biol Chem 271: 14825–14833
Barnes PJ, Basbaum CB, Nadel JA, Roberts JM (1982) Localization of betaadrenoreceptors in mammalian lung by light microscopic autoradiography. Nature 299: 444–447
Barnes PJ (1995) Beta-adrenergic receptors and their regulation Am J Respir Crit Care Med 152: 838–860
Torphy TJ (1994) γ-Adrenoceptors/cAMP and airway smooth muscle relaxation: challenges to the dogma. Trends Pharmacol Sci 15: 370–374
Kume H, Graziano MP, Kotlikoff MI (1992) Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc Nat Acad Sci (USA) 89: 11051–11055
Yamamoto KK, Gonzalez GA, Biggs WH III, Montminy MR (1989) Phosphorylation-iduced binding and transcriptional efficacy of nuclear factor CREB. Nature 334: 494–498
Gonzalez GA, Montminy MR (1989) Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675–680
Sasaki K, Cripe TP, Koch SR, Andreone TL, Petersen DD, Beale EG, Granner DK (1984) Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem 259: 15242–15251
Nigg EA, Hilz H, Eppenberger HM, Dutly F (1985) Rapid and reversible translocation of the catalytic subunit of cAMP-dependent protein kinase type II from the Golgi complex to the nucleus. EMBO J 4: 2801–2806
Kwok RPS, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SGE, Green MR, Goodman RH (1994) Nuclear protein CBP is a co-activator for the transcription factor CREB. Nature 370: 223–226
Kobierski LA, Chu H-M, Tan Y, Comb MJ (1991) cAMP-dependent regulation of proenkephalin by JunD and JunB: positive and negative effects of AP-1 proteins Proc Natl Acad Sci USA 88: 10222–10226
Masquilier D, Sassone-Corsi P (1992) Transcriptional cross-talk: nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J Biol Chem 267: 22460–22466
Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signallling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1069
Serkkola E, Hurme M (1993) Synergism between protein-kinase C and cAMP-dependent pathways in the expression of the interleukin-113 gene is mediated via the activator-protein-1 (AP-1) enhancer activity. Eur J Biochem 213: 243–249
Hai T, Curran T (1991) Cross family dimerisation of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 88: 3720–3724
Lalli E, Sassone-Corsi P (1994) Signal transduction and gene regulation: the nuclear response to cAMP. J Biol Chem 269: 17359–17362
Collins S, Bouvier M, Bolanowski MA, Caron MG, Lefkowitz RJ (1989) cAMP stimulates transcription of the beta 2-adrenergic receptor gene in response to short term agonist exposure. Proc Natl Acad Sci USA 86: 4853–4857
Collins S, Altschmied J, Herbsman O, Caron MG, Mellon PL, Lefkowitz RJ (1990) A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP. J Biol Chem 265: 19330–19335
Hadcock JR, Malbon CC (1988) Regulation of beta-adrenergic receptors by “permissive” hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc Natl Acad Sci USA 85: 8415–8419
Mak JCW, Nishikawa M, Barnes PJ (1995) Glucocorticosteroids increase β2-adrenergic receptor transcription in human lung. Am J Physiol 268: L41 - L46
Nishikawa M, Mak JC, Shirasaki H, Barnes PJ (1993) Differential down-regulation of pulmonary beta 1- and beta 2-adrenocepter messenger RNA with prolonged in vivo infusion of isoprenaline. Eur J Pharmacol 247: 131–138
Davis AO, Lefkowitz RJ (1984) Regulation of β-adrenergic receptors by steriod hormones. Annu Rev Physiol 46: 119–130
Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RAF, Keller P, Caron MG, Lefkowitz RJ (1987) Delineation of the intronless nature of the genes for the human and hamster β2-adrenergic receptor and their putative promoter regions. J Biol Chem 262: 7321–7327
Malbon CC, Hadcock JR (1988) Evidence that glucocorticoid response elements in the 5’ -noncoding region of the hamster beta 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels. Biochem Biophys Res Commun 154: 676–681
Dooley DJ, Bittiger H, Reymann NC (1986) CGP 20712 A: a useful tool for quantitating β1- and β2- adrenoceptors. Eur J Pharmacol 130: 137–139
Mak JCW, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ (1995) Protective effects of dexamethasone on isoproterenol-induced down-regulation of pulmonary β2R. J Clin Invest 96: 99–106
Galant SP, Duriseti L, Underwood S, Insel PA (1978) Decreased betaadrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 299: 933–936
Hauck RW, Bohm M, Gengenbach S, Sunder-Plassmann L, Fruhmann G, Erdmann E (1990) Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest 98: 376–381
Schule R, Muller M, Otsuka-Murakami H, Renkawitz R (1988) Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature 332: 87–90
Strahle U, Schmid W, Schutz G (1988) Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J 7: 3389–3395
Stauber C, Altschmied J, Akerblom IE, Marron JL, Mellon PL (1992) Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biologist 4: 527–540
Peters MJ, Adcock IM, Brown CR, Barnes PJ (1995) β-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharm (Mol Pharm) 289: 275–281
Drouin J, Charron J, Gagner JP, Jeannotte L, Nemer M, Plante RK, Wrange O (1987) Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J Cell Biochem 35: 293–304
Schule R, Rangarajan P, Kliewer S, Ransome LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between onco-protein c-jun and the glucocorticoid receptor. Cell 62: 1217–1226
Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J, Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205–1215
Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahari T, Matsushima K (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor kappa B is the target for glucocorticoid-mediated interleukin-8 gene repression. J Biol Chem 269: 13289–13295
Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ (1997) Evidence for involvement of NF-xB in the transcriptional control of cox-2 gene expression by IL-lβ. Biochem Biophys Res Comm 237: 46–50
Scarceriaux V, Pelaprat D, Forgez P, Lhiaubert AM, Rostene W (1995) Effects of dexamethasone and forskolin on neurotensin production in rat hypothalamic cultures. Endocrinology 136: 2554–2560
Kathju S, Heaton JH, Bruzdzinski CJ, Gelehrter TD (1994) Synergistic induction of tissue-type plasminogen activator gene expression by glucocorticoids and cyclic nucleotides in rat HTC hepatoma cells. Endocrinology 135: 1195–1204
Hinko A, Soloff MS (1993) Up-regulation of oxytocin receptors in rabbit amnion by glucocorticoids: potentiation by cyclic adenosine 3’,5’-monophosphate. Endocrinology 133: 1511–1519
Michel MC, Knapp J, Ratjen H (1994) Sensitisation by dexamethasone of lymphocyte cyclic AMP formation: evidence for increased function of the adenylyl cyclase catalyst. Br J Pharmacol 113: 240–246
Liu J-L, Papachristou DN, Patel YC (1994) Glucocorticoids activate somatostatin gene transcription through cooperative interaction with the cyclic AMP signalling pathway. Biochem J 301: 863–869
Dong Y, Aronsson M, Gustaffson J-A, Okret S (1989) The mechanism of cAMP-induced glucocorticoid receptor expression: Correlation to cellular glucocorticoid response. J Biol Chem 264: 13679–13683
Nordeen SK, Moyer ML, Bona BJ (1994) The coupling of multiple signal transduction pathways with steroid response mechanisms. Endocrinology 134: 1723–1732
Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268: 5353–5356
Jenab S, Inturrisi CE (1995) Proenkephalin gene expression: interaction of glucocorticoid and cAMP regulatory elements. Biochem Biophys Res Comm 210: 589–599.
Newton R, Kuitert LM, Barnes PJ, Adcock IM (1995) Stimulation of COX-2 message by cytokines of phorbol ester is preceded by a massive and rapid induction of NF-1(13 binding activity. Am J Resp Crit Care Med 151: A165
Kunz D, Walker G, Pfeilschifter J (1994) Dexamethasone differentially affects interleukin β- and cAMP-induced nitric oxide synthase mRNIt expression in renal mesangial cells. Biochem J 304: 337–340
Franckhauser S, Antras-Ferry J, Robin P, Robin D, Granner DK, Forest C et al (1995) Expression of the phosphoenolpyruvate carboxykinase gene in 3T3–F442A adipose cells: opposite effects of dexamethasone and isoprenaline on transcription. Biochem J 305: 65–71
Beale EG, Chrapkiewicz NB, Scoble HA, Metz RJ, Quick DP, Noble RL, Donelson JE, Biemann K, Granner DK (1985) Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene. J Biol Chem 260: 10748–60
Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW (1996) Regulation of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 271: 5301–5304
Schmoll D, Allan BB, Burchall A (1996) Cloning and sequencing of the 5’ region of the human glucose-6-phosphate gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE cells. FEBS Letts 383: 63–66
Pennie WD, Hager GL, Smith CL (1995) Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway. Mol Cell Biol 15: 2125–2134
Peters MJ, Adcock IM, Brown CR, Barnes PJ (1993) β-Agonist inhibition of steroid-receptor DNA binding activity in human lung. Am Rev Respir Dis 147: A772
Stevens DA, Barnes PJ, Adcock IM (1995) β-Agonists inhibit DNA binding of glucocorticoid receptors in human pulmonary and bronchial epithelial cells. Am J Respir Crit Care Med 151: A195
Adcock IM, Peters MJ, Kwon OJ, Corrigan G, Barnes PJ (1994) Glucocorticoid receptor interactions with cAMP response element binding protein (CREB) in specific target cells in the lung. Am J Respir Crit Care Med 149: A 1026
Carstairs JR, Nimmo AJ, Barnes PJ (1985) Autoradiographic visualization of beta-adrenoreceptor subtypes in human lung. Am Rev Respir Dis 132: 541–547
Adcock IM, Gilbey T, Gelder CM, Chung KF, Barnes PJ (1996) Glucocorticoid receptor localisation in normal and asthmatic lung. Am J Respir Crit Care Med 154: 771–782
Arai K, Lee F, Miyajima A, Miyatake S, Arai N, Yokota T (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59: 783–836
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Adcock, I.M., Stevens, D.A. (1998). Molecular interactions between glucocorticoids and β2-agonists. In: Kummer, F. (eds) Treatment of Asthma: The long-acting beta-2-agonists. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7513-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7513-2_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83124-3
Online ISBN: 978-3-7091-7513-2
eBook Packages: Springer Book Archive